Published in Psychol Med on May 01, 1999
Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci U S A (2003) 3.29
Childhood trauma associated with smaller hippocampal volume in women with major depression. Am J Psychiatry (2002) 3.05
Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci Biobehav Rev (2009) 2.44
The role of the hippocampus in the pathophysiology of major depression. J Psychiatry Neurosci (2004) 2.43
A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. J Psychiatry Neurosci (2009) 2.41
Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues Clin Neurosci (2008) 2.30
Modifiable factors that alter the size of the hippocampus with ageing. Nat Rev Neurol (2012) 1.71
Defining the human hippocampus in cerebral magnetic resonance images--an overview of current segmentation protocols. Neuroimage (2009) 1.68
Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression. JAMA (2003) 1.67
Hippocampal morphology and distinguishing late-onset from early-onset elderly depression. Am J Psychiatry (2007) 1.56
Imaging phenotypes of major depressive disorder: genetic correlates. Neuroscience (2009) 1.49
Medial temporal structures and memory functions in adolescents with heavy cannabis use. J Psychiatr Res (2011) 1.36
Hippocampal volume in early onset depression. BMC Med (2004) 1.35
Neuroanatomical correlates of personality in the elderly. Neuroimage (2007) 1.25
Change in hippocampal volume on magnetic resonance imaging and cognitive decline among older depressed and nondepressed subjects in the neurocognitive outcomes of depression in the elderly study. Am J Geriatr Psychiatry (2011) 1.21
The functional neuroanatomy of geriatric depression. Int J Geriatr Psychiatry (2009) 1.16
Volume deficits of subcortical nuclei in mood disorders A postmortem study. Eur Arch Psychiatry Clin Neurosci (2005) 1.10
Survey of protocols for the manual segmentation of the hippocampus: preparatory steps towards a joint EADC-ADNI harmonized protocol. J Alzheimers Dis (2011) 1.08
Depressive symptoms, brain volumes and subclinical cerebrovascular disease in postmenopausal women: the Women's Health Initiative MRI Study. J Affect Disord (2011) 1.02
Hippocampus shape analysis and late-life depression. PLoS One (2008) 1.02
The brain-derived neurotrophic factor Val66Met polymorphism, hippocampal volume, and cognitive function in geriatric depression. Am J Geriatr Psychiatry (2010) 0.98
Hippocampal volumes and the brain-derived neurotrophic factor val66met polymorphism in geriatric major depression. Am J Geriatr Psychiatry (2011) 0.97
Distinct functional networks associated with improvement of affective symptoms and cognitive function during citalopram treatment in geriatric depression. Hum Brain Mapp (2010) 0.91
Associations of current and remitted major depressive disorder with brain atrophy: the AGES-Reykjavik Study. Psychol Med (2012) 0.90
Depression, hippocampal volume changes, and cognitive decline in a clinical sample of older depressed outpatients and non-depressed controls. Aging Ment Health (2012) 0.90
The co-existence of geriatric depression and amnestic mild cognitive impairment detrimentally affect gray matter volumes: voxel-based morphometry study. Behav Brain Res (2012) 0.89
Decreased quinolinic acid in the hippocampus of depressive patients: evidence for local anti-inflammatory and neuroprotective responses? Eur Arch Psychiatry Clin Neurosci (2014) 0.88
Structural neuroimaging of geriatric depression. Psychiatr Clin North Am (2011) 0.87
Magnetic resonance spectroscopy in the evaluation of treatment efficacy in unipolar major depressive disorder: a review of the literature. Funct Neurol (2012) 0.83
Posterior Cingulate and Lateral Parietal Gray Matter Volume in Older Adults with Depressive Symptoms. Brain Imaging Behav (2009) 0.81
Association between subcortical volumes and verbal memory in unmedicated depressed patients and healthy controls. Neuropsychologia (2012) 0.80
Towards automated detection of depression from brain structural magnetic resonance images. Neuroradiology (2013) 0.78
Involvement of brain-derived neurotrophic factor in late-life depression. Am J Geriatr Psychiatry (2013) 0.78
Structural neuroimaging of concomitant depressive symptoms in amnestic mild cognitive impairment: a pilot study. Dement Geriatr Cogn Dis Extra (2012) 0.77
Depressive Symptoms and Amygdala Volume in Elderly with Cerebral Small Vessel Disease: The RUN DMC Study. J Aging Res (2011) 0.76
Neuroplasticity in mood disorders. Dialogues Clin Neurosci (2004) 0.76
Structural imaging in late-life depression: association with mood and cognitive responses to antidepressant treatment. Am J Geriatr Psychiatry (2013) 0.76
Enhancing synaptic plasticity and cellular resilience to develop novel, improved treatments for mood disorders. Dialogues Clin Neurosci (2002) 0.75
Organic bases of late-life depression: a critical update. J Neural Transm (Vienna) (2013) 0.75
A specific pattern of gray matter atrophy in Alzheimer's disease with depression. J Neurol (2017) 0.75
miR-21-mediated tumor growth. Oncogene (2006) 9.90
Fabrication of microfluidic systems in poly(dimethylsiloxane). Electrophoresis (2000) 9.45
Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR. Proc Natl Acad Sci U S A (2001) 6.99
Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science (2001) 6.84
Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci U S A (2006) 6.33
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev (1998) 5.14
PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci U S A (1999) 4.90
Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell (1998) 4.77
The three-dimensional structure of canine parvovirus and its functional implications. Science (1991) 3.87
A null mutation in the human CNTF gene is not causally related to neurological diseases. Nat Genet (1994) 3.70
The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study. Leukemia (2008) 3.69
Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients. Antimicrob Agents Chemother (1992) 3.31
A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J Biol Chem (2000) 3.26
Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc Natl Acad Sci U S A (1999) 2.91
Fabrication of topologically complex three-dimensional microfluidic systems in PDMS by rapid prototyping. Anal Chem (2000) 2.81
Haplotype mapping and sequence analysis of the mouse Nramp gene predict susceptibility to infection with intracellular parasites. Genomics (1994) 2.80
Structural basis for self-association and receptor recognition of human TRAF2. Nature (1999) 2.74
Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases. Curr Biol (2000) 2.67
Correlation of the highest-energy cosmic rays with nearby extragalactic objects. Science (2007) 2.57
N-acylhomoserine-lactone-mediated communication between Pseudomonas aeruginosa and Burkholderia cepacia in mixed biofilms. Microbiology (2001) 2.51
Combined spinal and extradural anesthesia. Anesth Analg (1992) 2.47
Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain. Cell (2001) 2.43
Expression, self-assembly, and antigenicity of a snow mountain agent-like calicivirus capsid protein. J Clin Microbiol (1995) 2.43
Mox-1 and Mox-2 define a novel homeobox gene subfamily and are differentially expressed during early mesodermal patterning in mouse embryos. Development (1992) 2.43
Reverse transcriptase as the major determinant for selective packaging of tRNA's into Avian sarcoma virus particles. J Virol (1980) 2.42
A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. Am J Psychiatry (1994) 2.41
DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Virol (2001) 2.41
Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. Proc Natl Acad Sci U S A (1997) 2.37
Ultrasonography of the rotator cuff. A comparison of ultrasonographic and arthroscopic findings in one hundred consecutive cases. J Bone Joint Surg Am (2000) 2.30
A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling. J Cell Biol (1995) 2.30
Binding of peptides with basic residues to membranes containing acidic phospholipids. Biophys J (1991) 2.30
The structural basis for the recognition of diverse receptor sequences by TRAF2. Mol Cell (1999) 2.25
In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol (1998) 2.23
Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage. Am J Gastroenterol (1999) 2.22
Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071. Antimicrob Agents Chemother (1998) 2.19
Identification of calcification with MRI using susceptibility-weighted imaging: a case study. J Magn Reson Imaging (2009) 2.14
Yeast activators stimulate plant gene expression. Nature (1988) 2.13
Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. N Engl J Med (1992) 2.12
Morphometric and electron-microscopic analyses of the effects of gonadotropin-releasing hormone agonists on uterine leiomyomas. Arch Pathol Lab Med (1998) 2.11
Overdiagnosis of 21-hydroxylase late onset congenital adrenal hyperplasia: correlation of corticotropin test and human leukocyte antigen typing. Fertil Steril (1996) 2.09
Trial of relaxation in reducing coronary risk: four year follow up. Br Med J (Clin Res Ed) (1985) 2.07
Trisomy eight in ES cells is a common potential problem in gene targeting and interferes with germ line transmission. Dev Dyn (1997) 2.05
Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial. Br J Ophthalmol (2008) 2.03
Isoelectric focusing without ampholyte. Biochem Biophys Res Commun (1979) 2.02
Psychological comorbidity and length of stay in the general hospital. Am J Psychiatry (1991) 1.98
Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, AND p300/CBP. J Biol Chem (2001) 1.96
Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America. Proc Natl Acad Sci U S A (1996) 1.95
Difficulties and rewards in family care of the depressed older adult. Gerontologist (1992) 1.94
Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv (2001) 1.93
Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin Cancer Res (2001) 1.93
Changing prevalence of tuberculosis infection with increasing age in high-burden townships in South Africa. Int J Tuberc Lung Dis (2010) 1.92
The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol (1998) 1.91
A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol Infect (2009) 1.87
Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics. J Neurosci (2001) 1.86
PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2). Curr Biol (2001) 1.86
Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist. J Clin Invest (1997) 1.86
Longitudinal study of brain morphology in first episode schizophrenia. Biol Psychiatry (2001) 1.86
Septin: a factor in plasma that opsonizes lipopolysaccharide-bearing particles for recognition by CD14 on phagocytes. J Exp Med (1992) 1.85
The 1990-1991 outbreak of melioidosis in the Northern Territory of Australia: epidemiology and environmental studies. Southeast Asian J Trop Med Public Health (1993) 1.83
A proteomic analysis reveals the loss of expression of the cell death regulatory gene GRIM-19 in human renal cell carcinomas. Oncogene (2006) 1.78
Characterization of interleukin-1 receptor-associated kinase in normal and endotoxin-tolerant cells. J Biol Chem (2000) 1.78
Evaluation of the circle of Willis with three-dimensional CT angiography in patients with suspected intracranial aneurysms. AJNR Am J Neuroradiol (1995) 1.78
Construction and recovery of viable retroviral genomes carrying a bacterial suppressor transfer RNA gene. Science (1985) 1.77
Causes of death among people with convulsive epilepsy in rural West China: a prospective study. Neurology (2011) 1.77
TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. J Cell Sci (2001) 1.76
Benefit of intravenous antispasmodic (hyoscyamine sulfate) as premedication for colonoscopy. Gastrointest Endosc (1999) 1.76
Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry (1994) 1.72
Growth factors regulate the survival and fate of cells derived from human neurospheres. Nat Biotechnol (2001) 1.70
Stimulation of MAP-2 kinase activity in T lymphocytes by anti-CD3 or anti-Ti monoclonal antibody is partially dependent on protein kinase C. J Immunol (1990) 1.70
High-cooperativity coupling of electron-spin ensembles to superconducting cavities. Phys Rev Lett (2010) 1.69
Visualization of Syk-antigen receptor interactions using green fluorescent protein: differential roles for Syk and Lyn in the regulation of receptor capping and internalization. J Immunol (2001) 1.69
Autogenous grafts for condylar reconstruction in treatment of TMJ ankylosis: current concepts and considerations for the future. Int J Oral Maxillofac Surg (2011) 1.67
Susceptibility testing of clinical isolates of Enterococcus faecium and Enterococcus faecalis. J Clin Microbiol (1992) 1.67
Effect of infection control measures on the frequency of upper respiratory infection in child care: a randomized, controlled trial. Pediatrics (2000) 1.66
Plk3 functionally links DNA damage to cell cycle arrest and apoptosis at least in part via the p53 pathway. J Biol Chem (2001) 1.66
Breast irradiation postlumpectomy: development and evaluation of a decision instrument. J Clin Oncol (1995) 1.66
Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr. J Virol (1997) 1.65
Detection of mecA, femA, and femB genes in clinical strains of staphylococci using polymerase chain reaction. Epidemiol Infect (1994) 1.64
Molecular basis for CD40 signaling mediated by TRAF3. Proc Natl Acad Sci U S A (2000) 1.64
Cell cycle-dependent repair of double-strand DNA breaks in a gamma-ray-sensitive Chinese hamster cell. Somat Cell Mol Genet (1985) 1.63
Evaluation of commercial and standard methodology for determination of oxacillin susceptibility in Staphylococcus aureus. J Clin Microbiol (1992) 1.62
Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder. Arch Gen Psychiatry (1999) 1.61
Genetically defined mouse models that mimic natural aspects of human prostate cancer development. Endocr Relat Cancer (2004) 1.61
Regulatable gene expression systems for gene therapy applications: progress and future challenges. Mol Ther (2005) 1.61
Characterization of novel simian immunodeficiency viruses from red-capped mangabeys from Nigeria (SIVrcmNG409 and -NG411). J Virol (2001) 1.61
Passive and active smoking and breast cancer risk in Canada, 1994-97. Cancer Causes Control (2000) 1.60
Specific killing of tumor cells in vitro in the presence of normal lymphoid cells and sera from hosts immune to the tumor antigens. Int J Cancer (1972) 1.60
Cognitive and behavioral precursors of schizophrenia. Dev Psychopathol (1999) 1.60
PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer. Oncogene (2006) 1.59
The spectrum of HIV-1 related cancers in South Africa. Int J Cancer (2000) 1.58
NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response. Oncogene (2010) 1.58
Impaired endothelial function and increased carotid stiffness in 9-year-old children with low birthweight. Circulation (2000) 1.58
Morphology of single olivocerebellar axons labeled with biotinylated dextran amine in the rat. J Comp Neurol (1999) 1.57
Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. Proc Natl Acad Sci U S A (1997) 1.57
Scavenger receptor A gene regulatory elements target gene expression to macrophages and to foam cells of atherosclerotic lesions. Proc Natl Acad Sci U S A (1995) 1.56
Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system. Public Health (2003) 1.55
Circulating megakaryocytes and platelet release in the lung. Blood (1965) 1.55